Article Information
PubMed
History
- Published online August 11, 2008.
Copyright & Usage
© 2008 Canadian Medical Association
Author Information
- Laura E. Targownik MD MSHS,
- Lisa M. Lix PhD,
- Colleen J. Metge PhD,
- Heather J. Prior MSc,
- Stella Leung MSc,
- William D. Leslie MD
- From the Departments of Gastroenterology (Targownik) and General Internal Medicine (Leslie), Division of Internal Medicine, the Department of Radiology (Leslie), Division of Nuclear Medicine, the Faculty of Pharmacy (Metge), and the Manitoba Centre for Health Policy, Department of Community Health Sciences, Faculty of Medicine (Targownik, Lix, Metge, Prior, Leung), University of Manitoba, Winnipeg, Man.
- Correspondence to:
Dr. William D. Leslie, C5121 St. Boniface Hospital, 409 Taché Ave., Winnipeg MB R2H 2A6; bleslie{at}sbgh.mb.ca
Statistics from Altmetric.com
Cited By...
In this issue
Article tools
Respond to this article
Jump to section
Related Articles
Cited By...
- Proton pump inhibitors inhibit PHOSPHO1 activity and matrix mineralisation in vitro
- Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study
- Quantitative examination of the bone health status of older adults with intellectual and developmental disability in Ireland: a cross-sectional nationwide study
- Skeletal effects of a gastrin receptor antagonist in H+/K+ATPase beta subunit KO mice
- Drugs that may harm bone: Mitigating the risk
- The impact of medication on vitamin D status in older individuals
- Use of proton pump inhibitors and risk of hip fracture in relation to dietary and lifestyle factors: a prospective cohort study
- Balancing the Risks and Benefits of Proton Pump Inhibitors
- Use of Acid-Suppressive Drugs and Risk of Fracture: A Meta-analysis of Observational Studies
- Proton pump inhibitors and osteoporosis-related fractures
- Proton pump inhibitors and osteoporosis-related fractures
- Proton-Pump Inhibitors and Osteoporosis-Related Fracture
- Use of Proton-Pump Inhibitors Is Associated with Excess Risk for Osteoporosis-Related Fractures
- Proton pump inhibitors: balancing the benefits and potential fracture risks
More in this TOC Section
Similar Articles
Collections
